Genentech Issuing Refunds for 340B Overcharges

by Admin | August 29, 2013 12:57 pm

(UPDATED September 3, 2013 with comment from Genentech)

August 29, 2013—The biopharmaceutical giant Genentech will be providing refunds to 340B covered entities on 19 of its products sold from the third quarter of 2008 through the second quarter of 2011 due to a recalculation of its Medicaid average manufacturer prices and best prices, according to a notice by the company[1] posted on the Health Resources and Services Administration (HRSA) Office of Pharmacy Affairs (OPA) home page. 

You must be registered to read complete articles (it's quick, easy, and 100% free). Click here to register[2].    Already registered? Click here to login[3]. (340B Health members, Drug Discount Monitor subscribers, and 340B Coalition conference attendees: Use your existing username and password.)

Endnotes:
  1. a notice by the company: http://www.hrsa.gov/opa/programrequirements/manufacturerletters/2013/genentech.pdf
  2. Click here to register: https://secure.340bhealth.org/340Binformed/Subscribe.aspx
  3. Click here to login: http://340binformed.org/reader-login/

Source URL: https://340binformed.org/2013/08/genentech-issuing-refunds-for-340b-overcharges/

Copyright ©2025 340binformed.org unless otherwise noted.